Barclays lowered the firm’s price target on UnitedHealth (UNH) to $642 from $655 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q4 report. It estimates one-third of the 80-90 basis point one-time medical loss ration headwind is driven by Medicare Advantage rebates.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio